Depression in Women: Understanding the Gender Gap - Coursework Example

Discussion Question Question Prior providing treatment to the woman, it is decisive to have comprehensive knowledge related to the depression issueof the woman. In this regard, it is notable from the conversion that the woman has expressed of every possible symptom of depression and sadness. These include trouble in sleeping, impaired concentration, increased appetite, anxiety and fatigue. The woman was poorly groomed during the conversion and was extensively slow in response with minimal facial expression (Sublette, 2008).

Moreover, the conversion with the woman also implied of her feeling of hopelessness and helplessness, which is considered as a decisive symptom of depression. Another major symptom of depression remained unfolded, which is the unexplained pains and aches. These physical complaints of a depressed individual generally include headaches, aching muscles, back pain, and stomach pain (Sublette, 2008). In addition, before making decision about the therapy to be provided to the woman, there is a need to have additional information relating to different causes that include biological causes, social causes and psychological causes for depression (Sublette, 2008).

Question 2For the effective treatment of the woman, who has been suffering from depression accompanied by anxiety, trouble in sleeping, impaired concentration, body fatigue and others, psychotherapy is considered as the best approach (Hughes & Herron, 2014). The reason behind for selecting psychotherapy is that the woman does not have the symptom of unexplained pains and aches, which was identified later. It is worth mentioning that some of the symptoms of depression witnessed by the woman are of major concerns and are required to be effectively intervened.

These include trouble in sleeping, anxiety and impaired concentrations among others (Sublette, 2008). These symptoms are notable to be largely affecting the woman and hence, required to be cured with effective intervention. In this regard, effective psychotherapy would certainly resolve such symptoms (Hughes & Herron, 2014). Question 3Although the woman has witnessed considerable concern on account of her acute depression and the consequent symptoms but effective psychotherapy would certainly support her to recover.

Thus, there is no requirement of another approach for treatment of the same (Hughes & Herron, 2014). In this regard, the woman is needed to be provided with proper care as well as treatment services in primary care setting. Primary care setting will be significant for providing care services on the basis of treatment requirement of the woman (Hughes & Herron, 2014).Question 4Non-pharmacological treatment of psychotherapy is considered as the most suitable approach for the 41 year old woman, who is suffering from depression.

For effective psychotherapeutic treatment to the woman, there is a requirement of certain lifestyle alterations (Hughes & Herron, 2014). These include the development of interpersonal communication amid the family members, friends and others members in the community. It is also arguable that some of the drugs along with psychotherapy would be more effective in the recovery of the woman. In this regard, medicine such as Duloxetine - Cymbalta is recommended to be consumed 40-60 mg/day for 1 week.

The individual can consume the same for more than 1 week and once or twice a day depending upon the intensity of depression (WebMD LLC, 2015). Effective psychotherapy would also occur on identification of the key cause of anxiety and depression. Resolving the key cause would support the woman to overcome from the issue (Hughes & Herron, 2014). ReferencesHughes, C., & Herron, S. (2014). Cognitive behavioural therapy for mild to moderate depression and anxiety. UK: McGraw-Hill Education. Sublette, N. K. (2008).

Predictors of depressive and anxiety symptoms among African American HIV-positive Women. USA: ProQuest. WebMD LLC. (2015). Dosing & uses. Retrieved from http://reference.medscape.com/drug/cymbalta-duloxetine-342960